2015
DOI: 10.1016/j.ophtha.2014.11.025
|View full text |Cite
|
Sign up to set email alerts
|

Genetics and Disease Expression in the CNGA3 Form of Achromatopsia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
61
1
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 62 publications
(64 citation statements)
references
References 54 publications
1
61
1
1
Order By: Relevance
“…' The subjective responses used in this form of LDT testing lead to variation in the data, and a more objective method of measurement, such as electromyography 31 or lid-fissure measurement, 32 may be preferable in future studies. Although the variability inherent in such a subjective test precludes detailed analysis, a couple of general conclusions can be made: thresholds for the patients in our sample were in the normal range or above and thresholds were lower for short-wavelength stimuli than for long-wavelength stimuli.…”
Section: Light Discomfort Thresholdsmentioning
confidence: 99%
“…' The subjective responses used in this form of LDT testing lead to variation in the data, and a more objective method of measurement, such as electromyography 31 or lid-fissure measurement, 32 may be preferable in future studies. Although the variability inherent in such a subjective test precludes detailed analysis, a couple of general conclusions can be made: thresholds for the patients in our sample were in the normal range or above and thresholds were lower for short-wavelength stimuli than for long-wavelength stimuli.…”
Section: Light Discomfort Thresholdsmentioning
confidence: 99%
“…2,3 In other populations, CNGA3-associated ACHM seems to be more prevalent. 4,5 CNGA3 and CNGB3 mutations result in a loss of cone photoreceptor function in humans and in animals with mutations in the homologous genes. [6][7][8] Studies in mouse, sheep, and dog models of achromatopsia caused by mutations in the CNGA3 and CNGB3 genes indicate that gene augmentation therapy using a recombinant adeno-associated virus (AAV) vector expressing a normal CNGA3 or CNGB3 gene can produce the functional CNGA3 or CNGB3 proteins and restore cone photoreceptor function.…”
Section: Introductionmentioning
confidence: 99%
“…These measures have become increasingly used as indicators of visual function beyond early processing in primary visual cortex. With the advance of new treatments for rod and cone dystrophies, such as gene therapy (Bainbridge et al, 2015;Cideciyan et al, 2008;Jacobson et al, 2012;Komáromy et al, 2010;Sundaram et al, 2014;Zelinger et al, 2015) it is becoming increasingly important to understand how different aspects of visual function, including higher cortical visual functions, are influenced by rod and cone loss. Gaining an understanding of visual function in observers with healthy vision under light conditions designed to activate rods and/or cones will provide important baseline information for comparison with retinal dystrophy patients before and after treatment with new therapies.…”
Section: Introductionmentioning
confidence: 99%